JPRN-UMIN000030284已完成未知
Search for predicvite factors of anti-PD-1 antibody, pembrolizumab - Search for predicvite factors of anti-PD-1 antibody, pembrolizumab
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Positive HBS-ag and/or HCV-ab 2)Positive HIV-ab 3)the primary doctor judging inappropriate for entry
研究者
相似试验
已完成
不适用
Prospective pilot study of anti-PD-L1 antibody therapy in advanced non-small cell lung cancer patients who previously responded to anti-PD-1 antibodyadvanced non-small cell lung cancerJPRN-UMIN000031888Saitama medical university International medical Center20
招募中
不适用
Prospective study of anti-PD-1 antibody therapy in advanced non-small cell lung cancer patients who previously treated with anti-PD-L1 antibodylung cancerJPRN-UMIN000033657Japanese Red Cross Medical Center30
Unknown
2 期
Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCCHepatocellular CarcinomaNCT04174781Zhejiang University61
招募中
不适用
Prospective study of anti-PD-L1 antibody therapy in advanced non-small cell lung cancer patients who previously treated with anti-PD-1 antibodylung cancerJPRN-UMIN000033288Japanese Red Cross Medical Center30
招募中
不适用
Prospective observational study of anti-PD-L1 antibody drug atezolizumab for non small cell lung cancerJPRN-UMIN000035616Second division, Depertment of Internal Medicine, Hamamatsu University School of Medicine100